Israel Englander’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.48M | Sell |
31,500
-8,300
| -21% | -$1.72M | ﹤0.01% | 2606 |
|
|
2026
Q1 | $8.41M | Buy |
39,800
+23,200
| +140% | +$5M | ﹤0.01% | 2348 |
|
|
2025
Q4 | $3.41M | Sell |
16,600
-29,300
| -64% | -$5.51M | ﹤0.01% | 3424 |
|
|
2025
Q3 | $7.2M | Buy |
45,900
+5,500
| +14% | +$850K | ﹤0.01% | 2737 |
|
|
2025
Q2 | $6.79M | Sell |
40,400
-39,400
| -49% | -$5.85M | ﹤0.01% | 2660 |
|
|
2025
Q1 | $11M | Sell |
79,800
-205,400
| -72% | -$26.2M | 0.01% | 2087 |
|
|
2024
Q4 | $33.7M | Buy |
285,200
+208,500
| +272% | +$24.3M | 0.02% | 1080 |
|
|
2024
Q3 | $8.48M | Sell |
76,700
-40,000
| -34% | -$4.18M | ﹤0.01% | 2346 |
|
|
2024
Q2 | $11.5M | Sell |
116,700
-94,100
| -45% | -$9.59M | 0.01% | 1968 |
|
|
2024
Q1 | $23.6M | Buy |
210,800
+5,100
| +2% | +$550K | 0.01% | 1430 |
|
|
2023
Q4 | $20.7M | Sell |
205,700
-283,700
| -58% | -$28.1M | 0.01% | 1513 |
|
|
2023
Q3 | $42.5M | Buy |
489,400
+13,300
| +3% | +$1.2M | 0.02% | 815 |
|
|
2023
Q2 | $45M | Buy |
476,100
+175,800
| +59% | +$14.8M | 0.02% | 803 |
|
|
2023
Q1 | $22.7M | Buy |
300,300
+15,300
| +5% | +$1.15M | 0.01% | 1250 |
|
|
2022
Q4 | $21.9M | Buy |
285,000
+15,800
| +6% | +$1.2M | 0.01% | 1364 |
|
|
2022
Q3 | $17.9M | Buy |
269,200
+92,500
| +52% | +$5.86M | 0.01% | 1457 |
|
|
2022
Q2 | $9.24M | Sell |
176,700
-107,800
| -38% | -$6.13M | 0.01% | 2134 |
|
|
2022
Q1 | $16.1M | Sell |
284,500
-111,500
| -28% | -$5.97M | 0.01% | 1611 |
|
|
2021
Q4 | $20.4M | Buy |
396,000
+359,500
| +985% | +$17.6M | 0.01% | 1420 |
|
|
2021
Q3 | $1.8M | Sell |
36,500
-139,500
| -79% | -$7.57M | ﹤0.01% | 4046 |
|
|
2021
Q2 | $10M | Buy |
176,000
+126,000
| +252% | +$7.36M | 0.01% | 1900 |
|
|
2021
Q1 | $3.04M | Buy |
+50,000
| New | +$2.76M | ﹤0.01% | 3121 |
|
|
2020
Q2 | – | Sell |
-10,000
| Closed | -$479K | – | 4190 |
|
|
2020
Q1 | $479K | Sell |
10,000
-155,000
| -94% | -$8.05M | ﹤0.01% | 2906 |
|
|
2019
Q4 | $8.35M | Buy |
165,000
+95,000
| +136% | +$4.91M | 0.01% | 1526 |
|
|
2019
Q3 | $3.3M | Buy |
70,000
+60,000
| +600% | +$2.74M | 0.01% | 2107 |
|
|
2019
Q2 | $471K | Sell |
10,000
-90,000
| -90% | -$4.15M | ﹤0.01% | 3278 |
|
|
2019
Q1 | $4.82M | Buy |
100,000
+25,000
| +33% | +$1.25M | 0.01% | 1792 |
|
|
2018
Q4 | $3.35M | Sell |
75,000
-20,000
| -21% | -$1.04M | 0.01% | 1864 |
|
|
2018
Q3 | $5.13M | Buy |
+95,000
| New | +$4.86M | 0.01% | 1774 |
|
Other funds holding CAH
Israel Englander's CAH Position: Q2 2026 in Review
Israel Englander reduced its Cardinal Health (CAH) stake by 63% in Q2 2026, selling an estimated $88.3M and leaving 254,734 shares worth $60.5M. The position accounts for 0.02% of the portfolio, ranked #783.
Israel Englander first reported a position in CAH in Q2 2013 and has held it in 48 quarters since. The position peaked at $402M in Q4 2024. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Israel Englander held 254,734 shares of Cardinal Health worth $60.5M as of Q2 2026.
- Israel Englander sold 424,949 Cardinal Health shares in Q2 2026, an estimated $88.3M.
- Cardinal Health made up 0.02% of Israel Englander's portfolio in Q2 2026, its #783 holding.
- Israel Englander first reported a position in Cardinal Health in Q2 2013 and has held it in 48 quarters since.
- Israel Englander's Cardinal Health position peaked at $402M in Q4 2024.
- 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.